Omeprazole It is the prototype member of substituted benzimidazoles which inhibit the final common step in gastric acid secretion. The PPIs have overtaken H2 blockers for acid-peptic disorders. The only significant pharmacological action of omeprazole is dose dependent suppression of gastric acid secretion; without anticholinergic or H2 blocking action. It is a powerful inhibitor of … Continue reading Omeprazole/Lansoprazole/Pantoprazole/Rabeprazole/Esomeprazole
